Dermata Therapeutics, Inc. (DRMA) income statement
DRMANasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.51−0.02 (-4.23%)
Close on Nov 20, 2026Market cap $2.05MP/E –Yield –
Dermata Therapeutics, Inc. financial ratios
See a number that looks wrong?